AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Surge Analysis
/
GT Biopharma, Inc.
/
2026-05-14
▲ SURGE
GT Biopharma, Inc.
+38.6%
GTBP
NASDAQ
Healthcare
2026-05-14
0.434
Close
0.313
Prev Close
+38.59%
Change
78.4x
Vol Ratio
Why It Surged
No related news available.
Related News
Connect Biopharma raises $20.2M, extends cash runway into 2027
Stocktitan
2026-03-30
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Weeklyvoice
2026-04-06
지아이이노베이션, 임상시험계획 승인 신청 공시
digitaltoday
2026-02-24
Connect Biopharma (CNTB) to Release Earnings on Monday
Themarketsdaily
2026-03-29
BTIG Reiterates Buy Rating on Connect Biopharma Hldgs (CNTB)
Gurufocus
2026-03-31
Technical Analysis
Signals
MACD Bullish
Above SMA20
Key Indicators
59.84
RSI (14)
0.35
SMA 20
0.26
Bollinger Lower
0.44
Bollinger Upper
0.35
Bollinger Mid
-0.01
MACD
-0.01
MACD Signal
0.01
MACD Hist
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
GT Biopharma, Inc. Surged +38.6% on 2026-05-14 — Analysis | Alpha Lenz